| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/AC0352171 |
| P698 | PubMed publication ID | 15018552 |
| P50 | author | Paul Tempst | Q25912123 |
| David Entenberg | Q52813474 | ||
| P2093 | author name string | Eric C Holland | |
| Josep Villanueva | |||
| John Philip | |||
| Carlos A Chaparro | |||
| Meena K Tanwar | |||
| P2860 | cites work | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | automation | Q184199 |
| matrix-assisted laser desorption/ionization | Q736400 | ||
| P304 | page(s) | 1560-1570 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Analytical Chemistry | Q485223 |
| P1476 | title | Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry | |
| P478 | volume | 76 |
| Q37499284 | A HSP60-targeting peptide for cell apoptosis imaging |
| Q34215634 | A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid |
| Q30826870 | A path or a new road in laboratory diagnostics? Biological mass spectrometry: facts and perspectives |
| Q34574653 | A prognostic biomarker for gastric cancer with lymph node metastases |
| Q28069912 | A review of novel analytical diagnostics for liquid biopsies: spectroscopic and spectrometric serum profiling of primary and secondary brain tumors |
| Q33302448 | A robust biomarker discovery pipeline for high-performance mass spectrometry data |
| Q33305170 | A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery |
| Q35174085 | Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition |
| Q34331151 | Aerobic sludge granulation: a tale of two polysaccharides? |
| Q34442495 | Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation |
| Q33294469 | Alternative profiling platform based on MELDI and its applicability in clinical proteomics |
| Q81517962 | An automated, sheathless capillary electrophoresis-mass spectrometry platform for discovery of biomarkers in human serum |
| Q79971083 | Analysis of peptides and proteins affinity-bound to iron oxide nanoparticles by MALDI MS |
| Q94131234 | Article Watch |
| Q33280949 | Automated serum peptide profiling |
| Q33231650 | Batch introduction techniques |
| Q38089951 | Biomarker rediscovery in diagnostics |
| Q33962458 | Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry. |
| Q36279065 | Cancer proteomics: many technologies, one goal |
| Q28254680 | Clathrate nanostructures for mass spectrometry |
| Q33246668 | Clinical proteomics and mass spectrometry profiling for cancer detection |
| Q36960733 | Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective |
| Q34007890 | Clustering with position-specific constraints on variance: applying redescending M-estimators to label-free LC-MS data analysis |
| Q34166788 | Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS. |
| Q33221189 | Correcting common errors in identifying cancer-specific serum peptide signatures |
| Q94101606 | Current Awareness on Comparative and Functional Genomics |
| Q36640047 | Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears |
| Q31108031 | Data analysis of assorted serum peptidome profiles |
| Q51567923 | Decomplexing biofluids using microchip based acoustophoresis. |
| Q37452720 | Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry |
| Q33631062 | Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry |
| Q34607497 | Detection of pancreatic cancer using serum protein profiling. |
| Q42015560 | Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine |
| Q34249148 | Detection of serum tumor markers in multiple myeloma using the CLINPROT system |
| Q33301109 | Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. |
| Q37174708 | Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry |
| Q37187745 | Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry |
| Q33945053 | Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology |
| Q33230965 | Differential exoprotease activities confer tumor-specific serum peptidome patterns |
| Q35541147 | Discrimination of normal and esophageal cancer plasma proteomes by MALDI-TOF mass spectrometry |
| Q33726479 | Effect of paricalcitol on the urinary peptidome of kidney transplant patients |
| Q57219481 | Efficacy of calcium supplementation for human bone health by mass spectrometry profiling and cathepsin K measurement in plasma samples |
| Q33217477 | Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery |
| Q36229479 | Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis |
| Q53556589 | Facile preparation of core-shell magnetic metal-organic framework nanospheres for the selective enrichment of endogenous peptides. |
| Q33764539 | Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis |
| Q34116114 | Functional protease profiling for diagnosis of malignant disease |
| Q38128148 | Functionalized magnetic nanoparticles for sample preparation in proteomics and peptidomics analysis |
| Q33210158 | High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry |
| Q33579375 | High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery |
| Q33262623 | Human body fluid proteome analysis |
| Q34377996 | Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry |
| Q37582071 | Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling |
| Q33361143 | Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues |
| Q33703086 | Impact of experimental and demographic variables in serum peptide profiling based on magnetic bead and MALDI-TOF mass spectrometry |
| Q34327104 | Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures |
| Q36735417 | In search of partners: linking extracellular proteases to substrates |
| Q34468372 | Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer |
| Q90669713 | Isolation and characterization of glycosylated neuropeptides |
| Q54984662 | LETTER FROM THE EDITOR. |
| Q33246070 | Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers |
| Q33217610 | MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer |
| Q33261717 | MALDI-TOF serum protein profiling for the detection of breast cancer |
| Q92192951 | Mass Spectrometry-Based Biomarkers in Drug Development |
| Q37484011 | Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective |
| Q38222153 | Mass spectrometry-based biomarkers in drug development |
| Q37171914 | Mass spectrometry-based proteomic profiling of lung cancer |
| Q33778668 | Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma. |
| Q36680064 | Mass spectrometry: uncovering the cancer proteome for diagnostics |
| Q33246543 | Material-enhanced laser desorption/ionization (MELDI)--a new protein profiling tool utilizing specific carrier materials for time of flight mass spectrometric analysis. |
| Q57759479 | Mesocylindrical Aluminosilica Monolith Biocaptors for Size-Selective Macromolecule Cargos |
| Q38297335 | Mesoporous materials modified by aptamers and hydrophobic groups assist ultra-sensitive insulin detection in serum |
| Q33519951 | Micro OS-ELISA: Rapid noncompetitive detection of a small biomarker peptide by open-sandwich enzyme-linked immunosorbent assay (OS-ELISA) integrated into microfluidic device |
| Q48690676 | Molecular staging of colorectal cancer: new paradigm or waste of time? |
| Q33484162 | Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry |
| Q36103993 | Multifunctional Magnetic Particles for Combined Circulating Tumor Cells Isolation and Cellular Metabolism Detection. |
| Q37176877 | Nanostructure initiator mass spectrometry: tissue imaging and direct biofluid analysis |
| Q36973774 | Nanotechnology in proteomics |
| Q34546734 | Non-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples. |
| Q37535606 | Optimization and evaluation of magnetic bead separation combined with matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy (MALDI-TOF MS) for proteins profiling of peritoneal dialysis effluent |
| Q33241392 | Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid |
| Q33301709 | Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range |
| Q37113905 | PEPPeR, a platform for experimental proteomic pattern recognition. |
| Q33545673 | Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting |
| Q33269730 | Peak selection from MALDI-TOF mass spectra using ant colony optimization |
| Q36505671 | Peptide profiling of cerebrospinal fluid by mass spectrometry |
| Q33914595 | Peptidome profiling of human serum of uveal melanoma patients based on magnetic bead fractionation and mass spectrometry |
| Q33959602 | Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases. |
| Q36950443 | Peptidomics analysis of human blood specimens for biomarker discovery |
| Q33221666 | Peptidomics: a logical sequel to proteomics |
| Q92559895 | Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis |
| Q37481709 | Perspectives of targeted mass spectrometry for protein biomarker verification |
| Q64235676 | Plasma Peptidome Pattern of Breast Cancer Using Magnetic Beads-Based Plasma Fractionation and MALDI-TOF MS: A Case Control Study in Egypt |
| Q35041471 | Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling |
| Q36841871 | Plasma/serum proteomics: pre-analytical issues. |
| Q36184782 | Population proteomics: addressing protein diversity in humans |
| Q36492806 | Population proteomics: the concept, attributes, and potential for cancer biomarker research |
| Q37114841 | Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling |
| Q33546553 | Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry |
| Q36144126 | Preliminary Study of Differentially Expressed Serum Peptides of Advanced NSCLC Patients Responsive to EGFR-TKI and Their Clinical Significance |
| Q34014727 | Preparation of magnetic core-mesoporous shell microspheres with C8-modified interior pore-walls and their application in selective enrichment and analysis of mouse brain peptidome |
| Q28727568 | Profiling plasma peptides for the identification of potential ageing biomarkers in Chinese Han adults |
| Q36561644 | Protein biomarker discovery and validation: the long and uncertain path to clinical utility |
| Q35226540 | Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS. |
| Q35913776 | Proteomic patterns for early cancer detection |
| Q57956888 | Proteomic profiling of a snake venom using high mass detection MALDI-TOF mass spectrometry |
| Q34259029 | Proteomic profiling of nephrotic syndrome in serum using magnetic bead based sample fractionation & MALDI-TOF MS. |
| Q33721224 | Proteomic profiling of uremia in serum using magnetic bead-based sample fractionation and MALDI-TOF MS |
| Q36736959 | Proteomic profiling of urine for the detection of colon cancer. |
| Q34395996 | Proteomic serum biomarkers and their potential application in cancer screening programs |
| Q31153300 | Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies |
| Q33602325 | Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling |
| Q30487094 | Quantitative matrix-assisted laser desorption/ionization mass spectrometry |
| Q36270602 | Rapid synthesis of titanium(IV)-immobilized magnetic mesoporous silica nanoparticles for endogenous phosphopeptides enrichment. |
| Q37579913 | Recent advances in mass spectrometry-based peptidome analysis |
| Q90714393 | Recent applications of paper-based point-of-care devices for biomarker detection |
| Q36731399 | Recent technical strategies to identify diagnostic biomarkers for ovarian cancer |
| Q38450951 | Revisiting cobalt chloride preconditioning to prevent hypobaric hypoxia-induced damage: identification of global proteomic alteration and key networks |
| Q36104460 | Salivary peptidome profiling for diagnosis of severe early childhood caries |
| Q36682379 | Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry |
| Q34499104 | Scrambling of autoinducing precursor peptides investigated by infrared multiphoton dissociation with electrospray ionization and Fourier transform ion cyclotron resonance mass spectrometry. |
| Q33702590 | Screening newborns for candidate biomarkers of type 1 diabetes |
| Q34109421 | Selective enrichment and sensitive detection of peptide and protein biomarkers in human serum using polymeric reverse micelles and MALDI-MS |
| Q61635745 | Serum Biomarkers of Renal Cell Carcinoma Assessed Using a Protein Profiling Approach Based on ClinProt Technique |
| Q33748762 | Serum Peptidome Profiling in Patients with Lung Cancer |
| Q28743469 | Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays |
| Q33322569 | Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry |
| Q40899284 | Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold |
| Q51230642 | Serum peptidome patterns for early screening of esophageal squamous cell carcinoma. |
| Q36645862 | Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis |
| Q34454987 | Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis |
| Q33955495 | Serum peptidome profiling in patients with gastric cancer |
| Q28397855 | Serum peptidome variations in a healthy population: reference to identify cancer-specific peptides |
| Q35034044 | Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC. |
| Q57556800 | Serum proteomics profiling—a young technology begins to mature |
| Q33943422 | Setup for human sera MALDI profiling: the case of rhEPO treatment |
| Q34418701 | Simultaneous extraction and rapid visualization of peptidomic and lipidomic body fluids fingerprints using mesoporous aluminosilicate and MALDI-TOF MS. |
| Q35842473 | Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer |
| Q92969750 | Synthesis of C8 -Functionalized Magnetic Graphene with a Polydopamine Coating for the Enrichment of Low-Abundance Peptides |
| Q33518746 | Synthesis of Fe(3)O(4)@SiO(2)@PMMA core-shell-shell magnetic microspheres for highly efficient enrichment of peptides and proteins for MALDI-ToF MS analysis |
| Q30952867 | Taxonomic relationships of pollens from matrix-assisted laser desorption/ionization time-of-flight mass spectrometry data using multivariate statistics |
| Q33289727 | Technology insight: the application of proteomics in gastrointestinal disease |
| Q44924621 | The blood peptidome: a higher dimension of information content for cancer biomarker discovery |
| Q36432402 | The proteomics big challenge for biomarkers and new drug-targets discovery |
| Q36195325 | The roles of multiple proteomic platforms in a pipeline for new diagnostics |
| Q30361936 | The use of proteomics to identify novel therapeutic targets for the treatment of disease. |
| Q36117662 | The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas |
| Q35973576 | Toxicoproteomics: proteomics applied to toxicology and pathology |
| Q59670812 | Ultrahigh resolution profiles lead to more detailed serum peptidome signatures of pancreatic cancer |
| Q37534352 | Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis. |
| Q34187912 | Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases. |
| Q33696558 | Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer |
| Q37455170 | Utility of mass spectrometry for proteome analysis: part II. Ion-activation methods, statistics, bioinformatics and annotation |
| Q31148237 | Whole-cell MALDI-TOF mass spectrometry is an accurate and rapid method to analyze different modes of macrophage activation |
Search more.